maprotiline hydrochloride Tablets 25 mg, 50 mg
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Israel
GMP approvals
EU GMP
Registered in
Israel
Available for
Licensing with supply
Manufacturer #8558
A pharmaceutical manufacturer that has been active for 40+ years.
The company's production lines are EU GMP-compliant. The company product is prepared in CTD dossier format.
The main dosage forms oral solid.
The main therapeutic areas include mental health, cardiology, and urology.
Manufacturer usually replies in 9 days
None